DOCSLIB.ORG

EXTRACORPOREAL LIFE SUPPORT ORGANIZATION 29Th ANNUAL ELSO CONFERENCE ABSTRACTS

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

EXTRACORPOREAL LIFE SUPPORT ORGANIZATION 29th ANNUAL ELSO CONFERENCE ABSTRACTS SCOTTSDALE, AZ September 13-16, 2018 Author Index .................................................................................................... Pages 87–92 Published in cooperation with the ASAIO Journal and available online at www.asaiojournal.com. 2018 ELSO Meeting Abstracts Table of Contents Outcomes of Pediatric Extracorporeal Life Support Patients with Veno-Venous Extracorporeal Membrane Oxygenation for Acute Bronchopulmonary Dysplasia and Associated Pulmonary Hypertension ...1 Respiratory Distress Syndrome Secondary to Choriamnionitis ................16 Outcomes After Long Veno-Venous ECMO Runs: A Case Series .................2 The Use of Venovenous Extracorporeal Membrane Oxygenation in Patients with Pulmonary Embolism..........................................................17 Traumatic Brain Injury is not a Contraindication To Veno-Venous Extracorporeal Membrane Oxygenation ....................................................2 Implementation of a Comprehensive ECMO Management Protocol Improves Survival among Patients with Severe ARDS ..............................17 V-V ECMO for Chlorine Inhalation Injury ....................................................3 CASE REPORT: Successful V-A-V ECMO Treatment in a patient with ARDS Early nutritional support is not associated with survival in adult patients and Cardiogenic shock caused by Streptococcus pyogenes .......................3 receiving veno-venous extracorporeal membranous oxygenation ..........18 Geriatric Extracorporeal Life Support has Acceptable Mortality and Malnutrition is associated with veno-venous extracorporeal membrane Discharge Outcomes ...................................................................................4 oxygenation duration and survival to discharge .......................................18 A Retrospective Review of the Use of a Dual Oxygenator Configuration Direct Measurement of Blood Gases in Tubing with Resonance Raman for VV and VA ECMO ..................................................................................4 Spectroscopy ............................................................................................19 Distal Perfusion Monitoring in the Femorally Cannulated A Multi-Discipline Approach to Early Extubation and Mobility for VA ECMO Patient ........................................................................................5 Patients on Veno-Venous Extracorporeal Membrane Oxygenation: A Case Series ............................................................................................20 Veno-Venous Extracorporeal Life Support To Facilitate Airway Foreign Body Removal In A Child With Severe Respiratory Failure .........................6 Veno-Venous Extracorporeal Membrane Oxygenation in a Jehovah’s Witness patient with acute respiratory distress syndrome secondary to Incidence and risk factors of serious neurologic injury in pediatric pneumonia and pulmonary embolism .....................................................20 survivors of extracorporeal life support .....................................................7 VV ECMO, Rapid Extubation, and Pulse Steroids for Near Fixed and Dilated Pupils: Is ECMO a consideration? ...................................7 Fatal Asthma .............................................................................................21 The learning curve of multidisciplinary team setups for venovenous Congenital alveolar capillary dysplasia - a rare cause of persistent extracorporeal membrane oxygenation in acute respiratory failure ..........8 pulmonary hypertension of the newborn ................................................21 Outcomes of Veno-Venous Extra-Corporeal Membrane Oxygenation Development of a Comprehensive Intramural ECLS Specialist Training when Stratified by Age – Is There a Point of No Return? ...........................8 Program: No Place like home ...................................................................22 Quality of life and functional status of patients treated with Venovenous Comparison of bivalirudin versus heparin-based anticoagulation for Extracorporeal Membrane Oxygenation at 6 Months ................................. 9 extracorporeal membrane oxygenation ...................................................22 Novel 6 Months Survival Prognostication Tool for Venovenous A free standing ECMO department: The benefits?...................................23 Extracorporeal Membrane Oxygenation ....................................................9 Combination of ECMO and cytokine adsorption therapy for patients Long Term VV ECMO Support and Repeat Peripheral Cannulation of a with pneumogenic sepsis and severe respiratory failure .........................24 Neonate with Necrotizing MRSA Pneumonia and Complicated Empyema ..................................................................................................10 Cytokine removal using the CytoSorb® system in combination with extra corporeal membrane oxygenation: a review of the literature. .......24 Correlation of Anti-Xa Levels and Thromboelastography R Times in Patients on Extracorporeal Life Support ...................................................11 Efficacy of postoperative inspiratory muscle training during ECMO Case Report. First-Presentation Status Asthmaticus Requiring therapy in patients with advanced pulmonary emphysema after lung Extracorporeal Cardio Pulmonary Resuscitation: Severe unresponsive volume reduction surgery ........................................................................25 asthma or delayed ECLS? ..........................................................................12 Successful Treatment of Severe Respiratory Failure HIV patients with Echocardiography as a Key Component in the Treatment of Adult Veno-Venous Extracorporeal Membrane Oxygenation: not a myth Veno-Venous Extra-Corporeal Membrane Oxygenation Patients: anymore ...................................................................................................26 A Review of Two Vanderbilt University Medical Center Adult Patients. ...13 Size Matters: Impact of Circuit Size on Coagulation and Hemolysis Outcome Analysis of Percutaneous Veno-Arterial Extracoroporeal Complications in Pediatric ECMO Patients ...............................................27 Memebrane Oxygenation as Bridge to Durable Left Ventricular Assist Evaluation of Serotonin Release Assay and ELISA Optical Density Device .......................................................................................................13 Tests in Patients Receiving Extracorporeal Membrane Oxygenation .......28 The Journey to ECMO could start with a single VAPE: A case of severe Mechanisms of platelet loss during pediatric extracorporeal life hypersensitivity pneumonitis in a pediatric patient .................................14 support (ECLS) ..........................................................................................28 Admistering Inhaled Alteplase (Tpa) as an Airway Clearance Adjunct Pediatric ECMO cannula complications: An under-reported source of After Pulmonary Hemorrage Causing Bronchial Blood Clots With Mucus ECMO morbidity .......................................................................................29 Plugging in Pediatric Patient During Ecmo ...............................................14 Neuromonitoring in Neonatal Extracorporeal Membrane Oxygenation Fungus Among Us: A case series of two pediatric patients diagnosed Patients .....................................................................................................29 with invasive fungal infections after Extracorporeal Membrane Oxygenation. ............................................................................................15 Outcomes of ECMO During CPR in Adult In-Hospital Cardiac Arrest ........30 Multidisciplinary Team Approach for Early Initiation of Extracorporeal Survival in Adult Venovenous and Venoarterial Extracorporeal Life Support for a Patient with Status Asthmaticus, Critical Airway, and Membrane Oxygenation Patients Compared to International Survival Mucopolysaccharidosis. ...........................................................................15 Prediction Scores: A Single Center Retrospective Review ........................30 Complex Management of Airway Bleeding on Veno-venous Factors Associated With Survival Following Extracorporeal Extracorporeal Membrane Oxygenation ..................................................16 Cardiopulmonary Resuscitation In Children .............................................31 2018 ELSO Meeting Abstracts Table of Contents Implementation of a Pediatric ECPR Program: Overcoming Comparison of Survival Indicators between Myocardial Infarction Challenges and Recognition of Safety Threats .........................................31 Patients and Septic Patients Who Received Veno-Arterial Extracorporeal Membrane Oxygenation Treatment .........................................................47 Trends in Cardiogenic Shock Treatment in an Institution New to Mechanical Circulatory Support ...............................................................32 Management Strategies during a Challenging VA ECMO Run in a Neonate with Septic Shock and Hypoxic Ischemic Encephalopathy: Development of a mobile adult ECMO program ......................................32 A Case Report ...........................................................................................48 ECMO for trauma patients: the experience at a Level
Recommended publications
  • Blood Collection

    Blood Collection

    Blood Collection (Note: Navigation around this large pdf document is best accomplished using the bookmarks function.) 355.1 Preface Blood collection (venipuncture, phlebotomy) is a common and important specimen collection procedure in the conduct of research. In many protocols, multiple blood draws are an important part of collecting and analyzing data. The Emory University Institutional Animal Care and Use Committee (IACUC) developed a policy to best enable blood collection while minimizing the potential for pain, unnecessary stress, distress or untoward effect in research animals. These are articulated by way of this general overview supplemented by companion documents appropriate to certain species. The species-specific sections differentiate from the general standards in being more precise, and sometimes more adaptable, in considering the frequency and total number of blood collection events; maximum collectable volumes allowed based upon specific physiology; detailing allowable routes particular to each species; differentiating between terminal and survival circumstances; disclosing requirements for anesthesia or restraint; scientific qualifiers and addressing conditionally permissible methods or settings germane to a species. This list is not exhaustive and persons requiring information regarding the supplies and equipment needed, specifics of restraint or anesthesia, requirements for ancillary care, habituation requirements, application to study in the field and other information are encouraged to contact the Training Coordinators for their specific site. o DAR Training Request: http://www.dar.emory.edu/forms/training_wrkshp.php o Yerkes National Primate Research Center Training: Jennifer McMillan, [email protected], 404-712-9217 While it only takes about 24 hours for the lost fluid volume of blood to be restored, it takes longer to regeneratively replenish erythrocytes, platelets and other circulating factors.
  • Digital Vein Mapping Guiding Laser and Injection Sclerotherapy to Treat Telangiectasias and Feeder Veins: Report of 140 Cases

    Digital Vein Mapping Guiding Laser and Injection Sclerotherapy to Treat Telangiectasias and Feeder Veins: Report of 140 Cases

    ARTÍCULO ORIGINAL Digital Vein Mapping Guiding Laser and Injection sclerotherapy to treat telangiectasias and Feeder Veins: Report of 140 Cases. Authors: Roberto Kasuo Miyake, MD, PhD / Rodrigo Kikuchi, MD / Flavio Henrique Duarte, MD / John Davidson, MD / Hiroshi Miyake, MD, PhD Institution: Clinica Miyake, Sao Paulo, Brazil E-Mail autor: [email protected] Fecha recepción artículo: 23/11/2008 - Fecha aceptación artículo: Marzo 2009 Abstract Resumen Background and Objective: Telangiectasias Antecedentes y Objetivo: la ineficiencia en el treatment inefficiency may occur due to tratamiento de las telangiectasias puede deber- invisible feeder veins. These veins can be made se a las venas nutricias no visibles. Estas venas discernible by use of a digital vein detection pueden hacerse perceptibles mediante el uso de device (V-V). This study evaluates a method un dispositivo digital de detección (VV). Este to treat vascular lesions by combining 1064nm estudio evalúa un método para el tratamiento laser, injection sclerotherapy, a skin cooling de lesiones vasculares mediante la combinación device (CLaCS) and the V-V. de láser de 1064nm, la escleroterapia por inyec- Materials and Methods: Patients were treated ción y un dispositivo de enfriamiento de la piel with laser and sclerotherapy, both applied (CLACS, Cryo-Laser y Cryo-Sclerotherapy)) y under cooling. V-V was used to visualize hidden el VV (The VeinViewer™). feeder veins. Material y Métodos: Los pacientes fueron trata- Results: A total of 140 patients underwent dos con láser y la escleroterapia, ambos aplicados CLaCS. In 121 patients (86%) satisfactory bajo enfriamiento con (CLaCS). El dispositivo cosmetic results were obtained avoiding digital V-V se utiliza para visualizar las venas phlebectomy.
  • Pulmonary Hypoplasia: a Rare Cause of Chronic Cough in TB Endemic Area

    Pulmonary Hypoplasia: a Rare Cause of Chronic Cough in TB Endemic Area

    Open Journal of Respiratory Diseases, 2019, 9, 18-25 http://www.scirp.org/journal/ojrd ISSN Online: 2163-9418 ISSN Print: 2163-940X Pulmonary Hypoplasia: A Rare Cause of Chronic Cough in TB Endemic Area Ouattara Khadidia1*, Kanoute Tenin1, Baya Bocar1, Soumaré Dianguina1, Kamian Youssouf Mama1, Sidibé Youssouf2, Fofana Aminata3, Traoré Mohamed Maba4, Guindo Ibrahim1, Sidibe Fatoumata1, Dakouo Aimé Paul1, Sanogo Fatoumata Bintou1, Bamba Salimata1, Coulibaly Lamine1, Yossi Oumar1, Kone Drissa Samba1, Toloba Yacouba1 1Department of Pneumology, University Teaching Hospital of Point G, Bamako, Mali 2Department of ENT, Secondary Hospital “Luxembourg”, Bamako, Mali 3Department of ENT, Nianakoro Fomba Hospital, Ségou, Mali 4Department of Radiology, Hospital of Mali, Bamako, Mali How to cite this paper: Khadidia, O., Abstract Tenin, K., Bocar, B., Dianguina, S., Mama, K.Y., Youssouf, S., Aminata, F., Maba, Pulmonary hypoplasia is a rare disease characterized by a defect of lung de- T.M., Ibrahim, G., Fatoumata, S., Paul, velopment more often unilateral. The diagnosis requires several exams to D.A., Bintou, S.F., Salimata, B., Lamine, C., eliminate other causes of pulmonary retraction. We report two cases at the Oumar, Y., Samba, K.D. and Yacouba, T. (2019) Pulmonary Hypoplasia: A Rare department of pneumophtisiology of the University Teaching Hospital of Cause of Chronic Cough in TB Endemic Point G. The first case is a young adult who was complaining of a chronic Area. Open Journal of Respiratory Diseas- cough. Etiological investigation required several exams including spirometry es, 9, 18-25. and Computed tomographic scan (CT scan). After elimination of all sus- https://doi.org/10.4236/ojrd.2019.91002 pected causes of pulmonary opacity, the diagnosis of pulmonary hypoplasia Received: November 30, 2018 was retained.

  • The Fetal Care Center at Weill Cornell Medicine

    The Fetal Care Center at NewYork-Presbyterian/ Weill Cornell Medicine Prompt and Personalized Care for Women with Complex Pregnancies A Team of Experts At the Fetal Care Center Our multidisciplinary team includes neonatologists (doctors with expertise caring for newborns with birth defects or at NewYork-Presbyterian/ complications associated with prematurity), maternal- fetal medicine specialists (obstetrician/gynecologists with Weill Cornell Medicine, additional training in maternal and fetal complications our experienced team of physicians is of pregnancy), and board-certified pediatric specialists, subspecialists, and pediatric surgeons. dedicated to providing high-quality, state-of-the-art care for you and your Prompt Attention baby. You can rest assured that you will We can make your first appointment quickly, sometimes within 24 business hours of your call. both receive the best possible medical care from the specialists you need Your First Visit in a supportive and compassionate You’ll meet with a neonatologist. We’ll connect you with an MFM specialist or any other doctors you need. environment. Our coordinator can assist you in arranging these appointments. We do our best to schedule as many appointments in the same day as we can, to minimize the number of visits you need to make to our center. We Have A Team of Experts Advanced Imaging the Team Our multidisciplinary team includes neonatologists (doctors We have state-of-the-art MRI capabilities to diagnosis and with expertise caring for newborns with birth defects or clarify complex conditions and help us determine the most You Need complications associated with prematurity), maternal- appropriate treatment options. fetal medicine specialists (obstetrician/gynecologists with additional training in maternal and fetal complications of Delivering Your Baby pregnancy), and board-certifi ed pediatric specialists and If you recently learned your baby subspecialists from every area of surgery and medicine.
  • Familial Lung Agenesis Concejo Iglesias P*, Martínez Perez M, Cubero Carralero J, Ocampo Toro WA, and Alvarez Cuenca JH

    Familial Lung Agenesis Concejo Iglesias P*, Martínez Perez M, Cubero Carralero J, Ocampo Toro WA, and Alvarez Cuenca JH

    Case Report iMedPub Journals Medical Case Reports 2020 www.imedpub.com Vol.6 No.2:137 ISSN 2471-8041 DOI: 10.36648/2471-8041.6.2.137 Familial Lung Agenesis Concejo Iglesias P*, Martínez Perez M, Cubero Carralero J, Ocampo Toro WA, and Alvarez Cuenca JH Department of Radiology, Hospital Universitario Severo Ochoa, Madrid, Spain *Corresponding author: Paula Concejo Iglesias, Hospital Universitario Severo Ochoa, Department of Radiology, Avda, De Orellana s/n, Leganés (Madrid) 28911, Spain, Tel: 914818000, E-mail: [email protected] Received date: April 22, 2020; Accepted date: May 22, 2020; Published date: May 28, 2020 Citation: Concejo-Iglesias P, Perez MM, Carralero JC, Toro WAO, Cuenca JHA (2020) Familial Lung Agenesis. Med Case Rep Vol.6 No.2: 137. Abstract Pulmonary agenesis (PA) is a very rare developmental anomaly of the lung. PA involving different members of a family is exceptional. Here, we report two cases of familial left pulmonary agenesis occurred in mother and daughter. Neither of them has other known malformations. Keywords: Pulmonary agenesis; Lung; Congenital disease; Familial disease Introduction Figure 1: PA Chest X-Ray of the mother made at age of 35 Pulmonary agenesis (PA) is a very rare congenital anomaly shows a diffuse opacity in the left hemithorax, mediastinum [1-5] of lung development defined as a complete absence of structures deviated to the left side with compensatory lung tissues, bronchi, and pulmonary vessels [3,6,7]. It may be hyperinflation of the right lung and decreased space uni- or bilateral [1,8] and may be associated with anomalies in between the left ribs.
  • Pulmonary Agenesis with Dextrocardia and Hypertrophic

    Pulmonary Agenesis with Dextrocardia and Hypertrophic

    eona f N tal l o B a io n l r o u g y o J Agarwal et al., J Neonatal Biol 2014, 3:3 Journal of Neonatal Biology DOI: 10.4172/2167-0897.1000141 ISSN: 2167-0897 Case Report Open Access Pulmonary Agenesis with Dextrocardia and Hypertrophic Cardiomyopathy: First Case Report Sheetal Agarwal, Arti Maria*, Dinesh Yadav and Narendra Bagri Department of Pediatrics, Ram Manohar Lohia Hospital, New Delhi, India *Corresponding author: Arti Maria, Dept. of Pediatrics, Ram Manohar Lohia Hospital, New Delhi, India, Tel: +919818618586; E-mail: [email protected] Rec date: April 17, 2014, 2014; Acc date: May 23, 2014; Pub date: May 25, 2014 Copyright: © 2014 Agarwal S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Pulmonary agenesis is a rare condition with complete absence of bronchus, lung tissue and vessels. A variety of cardiovascular defects are present in upto 1/3 rd cases of pulmonary agenesis. However, a combination of dextrocardia and hypertrophic cardiomyopathy in association with pulmonary agenesis is not known. Here we report the first case of a neonate presenting with respiratory distress since birth, diagnosed to have hypertrophic cardiomyopathy in association with dextrocardia, multiple cardiac defects and right lung agenesis. Association of heart disease with lung agenesis adversely affects the course and outcome making them a highly lethal association. Keywords: Pulmonary agenesis; Dextrocardia; Hypertrophic compromising cavity size without obstruction of left or right cardiomyopathy; Neonate ventricular outflow tracts.
  • Diagnostic Blood Loss from Phlebotomy and Hospital-Acquired Anemia During Acute Myocardial Infarction

    Diagnostic Blood Loss from Phlebotomy and Hospital-Acquired Anemia During Acute Myocardial Infarction

    ORIGINAL INVESTIGATION ONLINE FIRST |LESS IS MORE Diagnostic Blood Loss From Phlebotomy and Hospital-Acquired Anemia During Acute Myocardial Infarction Adam C. Salisbury, MD, MSc; Kimberly J. Reid, MS; Karen P. Alexander, MD; Frederick A. Masoudi, MD, MSPH; Sue-Min Lai, PhD, MS, MBA; Paul S. Chan, MD, MSc; Richard G. Bach, MD; Tracy Y. Wang, MD, MHS, MSc; John A. Spertus, MD, MPH; Mikhail Kosiborod, MD Background: Hospital-acquired anemia (HAA) during Results: Moderate to severe HAA developed in 3551 pa- acute myocardial infarction (AMI) is associated with tients(20%).Themean(SD)phlebotomyvolumewashigher higher mortality and worse health status and often de- in patients with HAA (173.8 [139.3] mL) vs those without velops in the absence of recognized bleeding. The ex- HAA (83.5 [52.0 mL]; PϽ.001). There was significant varia- tent to which diagnostic phlebotomy, a modifiable pro- tion in the mean diagnostic blood loss across hospitals (mod- cess of care, contributes to HAA is unknown. erate to severe HAA: range, 119.1-246.0 mL; mild HAA or no HAA: 53.0-110.1 mL). For every 50 mL of blood drawn, the risk of moderate to severe HAA increased by 18% (rela- Methods: We studied 17 676 patients with AMI from tiverisk[RR],1.18;95%confidenceinterval[CI],1.13-1.22), 57 US hospitals included in a contemporary AMI data- which was only modestly attenuated after multivariable ad- base from January 1, 2000, through December 31, 2008, justment (RR, 1.15; 95% CI, 1.12-1.18). who were not anemic at admission but developed mod- erate to severe HAA (in which the hemoglobin level de- Conclusions: Blood loss from greater use of phle- Ͻ clined from normal to 11 g/dL), a degree of HAA that botomy is independently associated with the develop- has been shown to be prognostically important.
  • Is Polidocanol Foam Sclerotherapy Effective in Treating Varicose Veins

    Is Polidocanol Foam Sclerotherapy Effective in Treating Varicose Veins

    Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Student Dissertations, Theses and Papers Scholarship 2016 Is Polidocanol Foam Sclerotherapy Effective in Treating Varicose Veins as Compared to Conventional Treatments? Sachi Patel Philadelphia College of Osteopathic Medicine, [email protected] Follow this and additional works at: http://digitalcommons.pcom.edu/pa_systematic_reviews Part of the Cardiovascular Diseases Commons Recommended Citation Patel, Sachi, "Is Polidocanol Foam Sclerotherapy Effective in Treating Varicose Veins as Compared to Conventional Treatments?" (2016). PCOM Physician Assistant Studies Student Scholarship. 291. http://digitalcommons.pcom.edu/pa_systematic_reviews/291 This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Physician Assistant Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For more information, please contact [email protected]. Is Polidocanol foam sclerotherapy effective in treating varicose veins as compared to conventional treatments? Sachi Patel, PA-S A SELECTIVE EVIDENCE BASED MEDICINE REVIEW In Partial Fulfillment of the Requirement for The Degree of Master of Science In Health Sciences- Physician Assistant Department of Physician Assistant Studies Philadelphia College of Osteopathic Medicine Philadelphia, Pennsylvania December 18, 2015 ABSTRACT OBJECTIVE: The objective of this selective EBM review is to determine whether or not Polidocanol foam sclerotherapy is effective in treating varicose veins as compared to conventional treatments. STUDY DESIGN: Review of three randomized controlled trials. All three studies are published in English between 2008 – 2012. DATA SOURCES: Three randomized control trials were found using PubMED and Medline.
  • A Case of Congenital Syndromic Hydrocephalus: a Subtype of ‘Game-Friedman- Paradice Syndrome'

    A Case of Congenital Syndromic Hydrocephalus: a Subtype of ‘Game-Friedman- Paradice Syndrome'

    Oman Medical Journal (2013) Vol. 28, No. 1:63-66 DOI 10. 5001/omj.2013.15 A Case of Congenital Syndromic Hydrocephalus: A Subtype of ‘Game-Friedman- Paradice Syndrome' Tapan Kumar Jana, Hironmoy Roy, Susmita Giri (Jana) Received: 06 Nov 2012 / Accepted: 20 Dec 2012 © OMSB, 2013 Abstract Human hydrocephalus is a disorder of abnormality in CSF flow various other anomalies. The condition was observed first in four or resorption, which has been classified in pertinent literature as offspring from one family and reported by Game K. et al. in 1989. congenital and acquired. Congenital hydrocephalus can present They postulated it to be an autosomal recessive inheritance.8 as an isolated phenomenon which is common; or with associated This syndrome is listed as a "rare disease" by the Office of Rare anomalies affecting other organs, disturbing physiology or presenting Diseases (ORD) of the National Institutes of Health (NIH). This as a syndrome. This report describes a case with congenital foetal means that Game-Friedman-Paradise syndrome, or a subtype hydrocephalus, hypoplastic lungs with super-numery lobations and of Game-Friedman-Paradice syndrome, affects less than one in large left lobe of liver compared to right. Thus far, a review of the 200,000 people in the US population.9 Unfortunately, to date, no literature indicates that this case can be postulated as a subtype of records have been found in the Indian population as searched for. Game-Friedman-Paradice syndrome. Case Report Keywords: Congenital hydrocephalus; Supernumery pulmonary lobations; Game-Friedman-Paradice syndrome. A 21-year-old full term, unbooked primigravida mother was brought in labor emergency in a prolonged first stage of labor.
  • APG Regulations

    APG Regulations

    FINAL as of 8/22/08 Pursuant to the authority vested in the Commissioner of Health by Section 2807(2-a) of the Public Health Law, Part 86 of Title 10 of the Official Compilation of Codes, Rules and Regulations of the State of New York, is amended by adding a new Subpart 86-8, to be effective upon filing with the Secretary of State, to read as follows: SUBPART 86-8 OUTPATIENT SERVICES: AMBULATORY PATIENT GROUP (Statutory authority: Public Health Law § 2807(2-a)(e)) Sec. 86-8.1 Scope 86-8.2 Definitions 86-8.3 Record keeping, reports and audits 86-8.4 Capital reimbursement 86-8.5 Administrative rate appeals 86-8.6 Rates for new facilities during the transition period 86-8.7 APGs and relative weights 86-8.8 Base rates 86-8.9 Diagnostic coding and rate computation 86-8.10 Exclusions from payment 86-8.11 System updating 86-8.12 Payments for extended hours of operation § 86-8.1 Scope (a) This Subpart shall govern Medicaid rates of payments for ambulatory care services provided in the following categories of facilities for the following periods: (1) outpatient services provided by general hospitals on and after December 1, 2008; (2) emergency department services provided by general hospitals on and after January 1, 2009; (3) ambulatory surgery services provided by general hospitals on and after December 1, 2008; (4) ambulatory services provided by diagnostic and treatment centers on and after March 1, 2009; and (5) ambulatory surgery services provided by free-standing ambulatory surgery centers on and after March 1, 2009.
  • Acr–Aser–Scbt-Mr–Spr Practice Parameter for the Performance of Pediatric Computed Tomography (Ct)

    Acr–Aser–Scbt-Mr–Spr Practice Parameter for the Performance of Pediatric Computed Tomography (Ct)

    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2019 (Resolution 6) * ACR–ASER–SCBT-MR–SPR PRACTICE PARAMETER FOR THE PERFORMANCE OF PEDIATRIC COMPUTED TOMOGRAPHY (CT) PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
  • Phlebotomy Student Handbook

    Phlebotomy Student Handbook

    LORAIN COUNTY COMMUNITY COLLEGE DIVISION OF HEALTH AND WELLNESS SCIENCES PHLEBOTOMY PROGRAM PHBT STUDENT HANDBOOK 2019-2020 SCHOOL YEAR CHERYL SELVAGE, MS MT(ASCP) Program Director June 2019 PHBT Student Handbook i LORAIN COUNTY COMMUNITY COLLEGE DIVISION OF HEALTH AND WELLNESS SCIENCES PHLEBOTOMY STUDENT HANDBOOK 2019-2020 School Year This handbook does not constitute a contract. The Program faculty reserve the right to revise this handbook at any time. Students will be given information regarding these changes either verbally or in a printed addendum. Prepared by: Cheryl Selvage, MS MT(ASCP) Clinical Laboratory Science Technology / Phlebotomy Program Director August 2019 PHBT Student Handbook ii TABLE OF CONTENTS TOPIC PAGE I. WELCOME ........................................................................................................... 1 II. INTRODUCTION................................................................................................... 1 A. History and Program Approval ....................................................................... 1 III. PURPOSE OF THE PHLEBOTOMY PROGRAM STUDENT HANDBOOK ........... 2 IV. PHILOSOPHY OF THE PHLEBOTOMY PROGRAM ............................................ 2 A. College Mission ............................................................................................... 2 B. Division of Health and Wellness ....................................................................... 3 C. PHBT Program Mission Statement .................................................................